AA
Akshay Anilrao Dalal
About Akshay Anilrao Dalal
Data last updated:
Akshay Anilrao Dalal is a Director at Ataraxia Pharma Private Limited (since 2023) and Director at Simpli Source Global Private Limited (since 2026). The companies operate in Pharma. The largest current company by reported revenue is Ataraxia Pharma Private Limited at ₹109 Cr (FY 2025). Earlier, Akshay Anilrao Dalal was a Director at Intellify Health Private Limited (2023–2024) and Director at Srujan Pharmaceuticals Private Limited (from 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ataraxia Pharma Private Limited U74999MH2018PTC315902 | Director | 29 Mar 2023 | 2018 | ₹109 Cr (FY 2025) | Active |
| Simpli Source Global Private Limited U46497MR2026PTC473564 | Director | 18 Feb 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Intellify Health Private Limited U46497MH2023PTC401607 | Director | 25 Apr 2023 | 2023 | ₹4.39 Cr (FY 2025) | Active |
| Srujan Pharmaceuticals Private Limited U24290MH2022PTC385915 | Director | 01 Jul 2022 | 2022 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Akshay Anilrao Dalal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sani Malose | 08259232 | Ataraxia Pharma Private Limited | Director |
| Rahul Singh | 07780205 | Simpli Source Global Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Akshay Anilrao Dalal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akshay Anilrao Dalal
Akshay Anilrao Dalal currently holds 2 directorships: Ataraxia Pharma Private Limited (Director, since 29 Mar 2023, revenue ₹109 Cr (FY 2025)); Simpli Source Global Private Limited (Director, since 18 Feb 2026).
Akshay Anilrao Dalal was first appointed on 01 Jul 2022 as Director at Srujan Pharmaceuticals Private Limited. The most recent appointment on record is 18 Feb 2026 at Simpli Source Global Private Limited.
Akshay Anilrao Dalal held 2 earlier board appointments: Intellify Health Private Limited (Director, 25 Apr 2023 to 26 Mar 2024); Srujan Pharmaceuticals Private Limited (Director, from 01 Jul 2022).
The current boards of Akshay Anilrao Dalal's companies include Sani Malose (Ataraxia Pharma Private Limited), Rahul Singh (Simpli Source Global Private Limited).